Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

101.90
CHF
+49.04
(+92.78%)
3.36EPS
Feb 23Next Earn

No stock splits recorded

Our records contain no stock splits for Halozyme Therapeutics, Inc. (BX:RV7).

Stock splits API